Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jun;71(6):1082-4.
doi: 10.1021/np800098f. Epub 2008 May 8.

Selective inhibition of aromatase by a dihydroisocoumarin from Xyris pterygoblephara

Denise C Endringer  1 , Keller G Guimarães, Tamara P Kondratyuk, John M Pezzuto, Fernão C Braga
Affiliations

Selective inhibition of aromatase by a dihydroisocoumarin from Xyris pterygoblephara

Denise C Endringer et al. J Nat Prod. 2008 Jun.

Abstract

Aromatase is a well-established target for the chemoprevention of breast cancer. The dihydroisocoumarin (3 R,4 R)-(-)-6-methoxy-1-oxo-3-pentyl-3,4-dihydro-1 H-isochromen-4-yl acetate (1) (IC 50 = 1.6 +/- 0.1 microM), isolated from aerial parts of Xyris pterygoblephara, showed aromatase inhibitory activity. The specificity of 1 was evaluated by inhibition assays with cytochrome P450 enzymes. CYP1A1 was inhibited modestly (IC 50 = 38.0 +/- 2.0 microM), while CYP2C8 and CYP3A4 enzymes were not affected. Dihydroisocoumarin 1 showed weak antiproliferative activity against MCF-7 (IC 50 = 66.9 +/- 2.3 microM) and LNCaP (IC 50 = 57.5 +/- 2.0 microM) cells and was inactive against LU-1 and HepG2 cells in culture. These results demonstrate the potential of dihydroisocoumarin 1 to serve as a selective aromatase inhibitor.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Dose-response studies of the inhibition of compound 1 on aromatase (CYP19) and CYP1A1. Results are the means of three assays, each one carried out in triplicate.
None
Chemical structure of dihydroisocoumarin (1) [(3R,4R)-(-)-6-methoxy-1-oxo-3-pentyl-3,4-dihydro-1H-isochromen-4-yl acetate]
See this image and copyright information in PMC

References

    1. Mastro LD, Clavarezza M, Venturini M. Cancer Treat Rev. 2007;33:681–687. - PubMed
    1. Briest S, Wolff AC. Expert Rev Anticancer Ther. 2007;7:1243–1253. - PubMed
    1. Maiti A, Cuendet M, Croy VL, Endringer DC, Pezzuto JM, Cushman M. J Med Chem. 2007;50:2799–806. - PubMed
    1. Smith IE, Dowsett M. N Engl J Med. 2003;348:2431–2442. - PubMed
    1. Wong ZW, Ellis MJ. Br J Cancer. 2004;90:20–25. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources